Lipanthyl Supra 160 10 Tablet

Name: Lipanthyl Supra 160 10 Tablets

description: LIPANTHYL SUPRA TABLET contains fenofibrate which is included in the fibrate group. Fenofibrate can reduce blood cholesterol by 20-25% and blood triglycerides by 40-50%.
The reduction in blood cholesterol is caused by a decrease in the ratio of atherogenic low density fractions (VLDL and LDL). Fenofibrate improves plasma cholesterol distribution because it reduces the total cholesterol/HDL ratio which increases during atherogenic hyperlipidemia.
This drug is used to lower serum triglyceride levels and increase HDL (good fat) levels in sufferers of Hypercholesterolemia (type IIa) and endogenous hypertriglyceridemia either isolated (type IV) or associated (type IIb & III) when the adjusted diet is insufficient, when blood cholesterol after dieting is still high and/or if there are associated risk factors. When using this medicine, you MUST ACCORD TO THE DOCTOR'S INSTRUCTIONS. Purchasing this drug requires education regarding the appropriate and safe use or consumption of the drug which will incur a fee.

composition: Each tablet contains Fenofibrate 160 mg

packaging: Box, 3 Blisters @ 10 Film Coated Tablets

how_to_use: Take with food.

side_effects: Medication use generally has certain side effects and depends on each individual. If excessive or dangerous side effects occur, please consult medical personnel.
Side effects that may occur when using the drug are:
Mild GI dyspepsia, allergic skin reactions, muscle pain with increased CPK, alopecia, sexual asthenia.

Warning: MUST BE WITH A DOCTOR'S PRESCRIPTION.
Stop if AST, ALT levels increase to >3 times ULN or 100 IU. Pancreatitis; muscle toxicity in patients with hypoalbuminemia, personal or family history of hereditary muscle disorders, hypothyroidism or high alcohol consumption. Patients with hyperlipidemia who use estrogen or estrogen-containing contraceptives. Avoid in patients with rare hereditary galactosemia, glucose malabsorption disorders, lactase deficiency, or sucrase isomaltase deficiency. Concomitant use with other fibrates & HMG-CoA reductase inhibitors. Discontinue if creatinine levels increase >50% ULN. Monitor creatinine during the first 3 months of treatment. Impaired kidney function. Elderly >70 years.

Pregnancy Category:
Category C: May be risky.
Drugs are used with caution if the benefits obtained outweigh the risks to the fetus. Research on animal tests shows risks to the fetus and there has been no direct research on pregnant women.
Consult medical personnel if you are breastfeeding.

Prescription information: Prescription needed. Trusted by Bali locals, tourists, expats, and nomads, BaliPharma ensures safety and reliability with convenient delivery across Bali, plus free online doctor consultations at BaliDoc.com for added ease and support.